• Autolus Therapeutics announces participation in upcoming conferences

    ソース: Nasdaq GlobeNewswire / 06 11 2023 07:00:00   America/New_York

    LONDON, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces its participation in three upcoming conferences in November.

    Truist Securities BioPharma Symposium
    Panel: Considerations for an Oncology Company’s Autoimmune Side Hustle
    Date and time: 9 November 2023, 11:40am ET / 16:40pm GMT
    Location: New York, USA
    Presenter: Dr Christian Itin, Chief Executive Officer, Autolus Therapeutics

    Jefferies London Healthcare Conference  
    Fireside Chat
    Date and time: 16 November 2023, 4:00am ET / 9:00am GMT
    Location: London, UK
    Presenter: Dr Christian Itin, Chief Executive Officer, Autolus Therapeutics

    Piper Sandler 35th Annual Healthcare Conference
    Fireside Chat
    Date and time: 28 November 2023, 11:30am ET/ 16:30pm GMT
    Location: New York, USA
    Presenter: Dr Christian Itin, Chief Executive Officer, Autolus Therapeutics

    Find out more information about upcoming events and any webcast and replay details at: https://www.autolus.com/investor-relations/events/

    About Autolus Therapeutics plc
    Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer and autoimmune disease. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize target cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. For more information, please visit www.autolus.com.

    Contact:

    Julia Wilson
    +44 (0) 7818 430877
    j.wilson@autolus.com

    Susan A. Noonan
    S.A. Noonan Communications
    +1-917-513-5303
    susan@sanoonan.com

    Lauren Williams
    Investase
    +44 23 9438 7760
    lauren@investase.com 


    Primary Logo

シェアする